{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:58:14Z","timestamp":1758124694253},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,11]]},"DOI":"10.7759\/cureus.66659","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:53:27Z","timestamp":1723442007000},"source":"Crossref","is-referenced-by-count":3,"title":["Unveiling the Quest: Crafting an Enzyme-Linked Immunosorbent Assay (ELISA) Technique to Uncover COVID-19 Antibodies"],"prefix":"10.7759","author":[{"given":"Nitin","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam V","family":"Suryawanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikanth","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.06.023","article-title":"Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort","volume":"27","author":"Berenguer J","year":"2021","unstructured":"Berenguer J, D\u00edez C, Mart\u00edn-Vicente M, et al.. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. Clin Microbiol Infect. 2021, 27:1678-84. 10.1016\/j.cmi.2021.06.023","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-020-11061-5","article-title":"Detection technologies and recent developments in the diagnosis of COVID-19 infection","volume":"105","author":"Rai P","year":"2021","unstructured":"Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol. 2021, 105:441-55. 10.1007\/s00253-020-11061-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5812\/archcid.110667","article-title":"Different laboratory diagnosis methods of COVID-19: a systematic review","volume":"16","author":"Omidifar N","year":"2021","unstructured":"Omidifar N, Bagheri Lankarani K, Moghadami M, et al.. Different laboratory diagnosis methods of COVID-19: a systematic review. Arch Clin Infect Dis. 2021, 16:10.5812\/archcid.110667","journal-title":"Arch Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2021.03.010","article-title":"SARS-Cov-2 seroprevalence and risk factors among health care workers: estimating the risk of COVID-19 dedicated units","volume":"49","author":"Oliveira MS","year":"2021","unstructured":"Oliveira MS, Lobo RD, Detta FP, et al.. SARS-Cov-2 seroprevalence and risk factors among health care workers: estimating the risk of COVID-19 dedicated units. Am J Infect Control. 2021, 49:1197-9. 10.1016\/j.ajic.2021.03.010","journal-title":"Am J Infect Control"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2232_20","article-title":"Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG","volume":"151","author":"Sapkal G","year":"2020","unstructured":"Sapkal G, Shete-Aich A, Jain R, et al.. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020, 151:444-9. 10.4103\/ijmr.IJMR_2232_20","journal-title":"Indian J Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00916-7","article-title":"SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1","volume":"29","author":"Sun X","year":"2022","unstructured":"Sun X, Liu Y, Huang Z, et al.. SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1. Cell Death Differ. 2022, 29:1240-54. 10.1038\/s41418-021-00916-7","journal-title":"Cell Death Differ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.778037","article-title":"Recent chronology of COVID-19 pandemic","volume":"10","author":"Siddiqui S","year":"2022","unstructured":"Siddiqui S, Alhamdi HW, Alghamdi HA. Recent chronology of COVID-19 pandemic. Front Public Health. 2022, 10:778037. 10.3389\/fpubh.2022.778037","journal-title":"Front Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.08.060","article-title":"Bio-safety and bio-security: a major global concern for ongoing COVID-19 pandemic","volume":"29","author":"Ali Al Shehri S","year":"2022","unstructured":"Ali Al Shehri S, Al-Sulaiman AM, Azmi S, Alshehri SS. Bio-safety and bio-security: a major global concern for ongoing COVID-19 pandemic. Saudi J Biol Sci. 2022, 29:132-9. 10.1016\/j.sjbs.2021.08.060","journal-title":"Saudi J Biol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01768-4","article-title":"Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections","volume":"19","author":"Luo J","year":"2022","unstructured":"Luo J, Brakel A, Krizsan A, et al.. Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections. Virol J. 2022, 19:50. 10.1186\/s12985-022-01768-4","journal-title":"Virol J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmab085","article-title":"Quantitative detection of anti-SARS-CoV-2 antibodies using indirect ELISA","volume":"53","author":"Luo S","year":"2022","unstructured":"Luo S, Xu J, Cho CY, et al.. Quantitative detection of anti-SARS-CoV-2 antibodies using indirect ELISA. Lab Med. 2022, 53:225-34. 10.1093\/labmed\/lmab085","journal-title":"Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2020.07.033","article-title":"Antiviral properties of placental growth factors: a novel therapeutic approach for COVID-19 treatment","volume":"99","author":"Joshi MG","year":"2020","unstructured":"Joshi MG, Kshersagar J, Desai SR, Sharma S. Antiviral properties of placental growth factors: a novel therapeutic approach for COVID-19 treatment. Placenta. 2020, 99:117-30. 10.1016\/j.placenta.2020.07.033","journal-title":"Placenta"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.22541\/au.159060695.58967402","article-title":"No evidence of re-infection or person-to-person transmission in cured COVID-19 patients, a retrospective cohort study","volume":"2020","author":"Xu G","year":"2020","unstructured":"Xu G, Liu F, Zhao J, et al.. No evidence of re-infection or person-to-person transmission in cured COVID-19 patients, a retrospective cohort study. Authorea. 2020, 2020:10.22541\/au.159060695.58967402","journal-title":"Authorea"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33973","article-title":"A rare case of persistent COVID-19 infection with aspergillosis in a 12-year-old child","volume":"15","author":"Reddy RM","year":"2023","unstructured":"Reddy RM, Taksande A, Lakra MS, Wanjari MB. A rare case of persistent COVID-19 infection with aspergillosis in a 12-year-old child. Cureus. 2023, 15:e33973. 10.7759\/cureus.33973","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4362126","article-title":"Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina","volume":"7","author":"Sciaudone M","year":"2023","unstructured":"Sciaudone M, Cutshaw M, McClean C, et al.. Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina. IJID Reg. 2023, 7:164-9. 10.2139\/ssrn.4362126","journal-title":"IJID Reg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050825","article-title":"A reliable indirect ELISA protocol for detection of human antibodies directed to SARS-CoV-2 NP protein","volume":"11","author":"Faizo AA","year":"2021","unstructured":"Faizo AA, Alandijany TA, Abbas AT, et al.. A reliable indirect ELISA protocol for detection of human antibodies directed to SARS-CoV-2 NP protein. Diagnostics (Basel). 2021, 11:825. 10.3390\/diagnostics11050825","journal-title":"Diagnostics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103140","article-title":"Whole blood derived covid convalescent plasma: a practical experience from India","volume":"60","author":"Mandal A","year":"2021","unstructured":"Mandal A, Chakrabarty R, Datta SS. Whole blood derived covid convalescent plasma: a practical experience from India. Transfus Apher Sci. 2021, 60:103140. 10.1016\/j.transci.2021.103140","journal-title":"Transfus Apher Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103794","article-title":"Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: impact of immunosuppressive treatment","volume":"62","author":"Jovicevic V","year":"2022","unstructured":"Jovicevic V, Ivanovic J, Momcilovic N, et al.. Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: impact of immunosuppressive treatment. Mult Scler Relat Disord. 2022, 62:103794. 10.1016\/j.msard.2022.103794","journal-title":"Mult Scler Relat Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2022-108436","article-title":"Association between COVID-19 infection and work exposure assessed by the Mat-O-Covid job exposure matrix in the CONSTANCES cohort","volume":"79","author":"Fadel M","year":"2022","unstructured":"Fadel M, Gilbert F, Legeay C, et al.. Association between COVID-19 infection and work exposure assessed by the Mat-O-Covid job exposure matrix in the CONSTANCES cohort. Occup Environ Med. 2022, 79:782-9. 10.1136\/oemed-2022-108436","journal-title":"Occup Environ Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.22271\/phyto.2021.v10.i1aa.13636","article-title":"Traditional Sri Lankan plant, Lantana camara; will it be a treatment against the hematological complications of COVID-19?","volume":"10","author":"Kottahachchi D","year":"2021","unstructured":"Kottahachchi D, Nandasena C, Sandarenu S, Kankanamge U, Withanawasam T. Traditional Sri Lankan plant, Lantana camara; will it be a treatment against the hematological complications of COVID-19?. J Pharmacogn Phytochem. 2021, 10:1948-51. 10.22271\/phyto.2021.v10.i1aa.13636","journal-title":"J Pharmacogn Phytochem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.01.002","article-title":"A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertiary care hospital in Taiwan","volume":"120","author":"Pan SC","year":"2021","unstructured":"Pan SC, Huang YS, Hsieh SM, Chen YC, Chang SY, Chang SC. A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertiary care hospital in Taiwan. J Formos Med Assoc. 2021, 120:1459-63. 10.1016\/j.jfma.2021.01.002","journal-title":"J Formos Med Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26303","article-title":"Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies","volume":"93","author":"Tr\u00e9-Hardy M","year":"2021","unstructured":"Tr\u00e9-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogn\u00e9 JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021, 93:803-11. 10.1002\/jmv.26303","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105580","article-title":"Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia","volume":"168","author":"Kinsella P","year":"2023","unstructured":"Kinsella P, Moso M, Martin G, et al.. Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia. J Clin Virol. 2023, 168:105580. 10.1016\/j.jcv.2023.105580","journal-title":"J Clin Virol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.30476\/jamp.2020.87332.1304","article-title":"Students' perception and learning on case based teaching in anatomy and physiology: an e-learning approach","volume":"9","author":"Vedi N","year":"2021","unstructured":"Vedi N, Dulloo P. Students' perception and learning on case based teaching in anatomy and physiology: an e-learning approach. J Adv Med Educ Prof. 2021, 9:8-17. 10.30476\/jamp.2020.87332.1304","journal-title":"J Adv Med Educ Prof"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2023.04.004","article-title":"Field evaluation of two commercial serological assays for detecting bovine tuberculosis","volume":"159","author":"Moens C","year":"2023","unstructured":"Moens C, Saegerman C, Fretin D, March\u00e9 S. Field evaluation of two commercial serological assays for detecting bovine tuberculosis. Res Vet Sci. 2023, 159:125-32. 10.1016\/j.rvsc.2023.04.004","journal-title":"Res Vet Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-022-05636-y","article-title":"Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia","volume":"168","author":"Kharroubi G","year":"2023","unstructured":"Kharroubi G, Cherif I, Ghawar W, et al.. Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia. Arch Virol. 2023, 168:69. 10.1007\/s00705-022-05636-y","journal-title":"Arch Virol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2020.08.011","article-title":"Detection of COVID-19 RNA: looking beyond PCR","volume":"77","author":"Singh S","year":"2021","unstructured":"Singh S, Batra TA, Misra P. Detection of COVID-19 RNA: looking beyond PCR. Med J Armed Forces India. 2021, 77:S511-2. 10.1016\/j.mjafi.2020.08.011","journal-title":"Med J Armed Forces India"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.042","article-title":"Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies","volume":"102","author":"Yassine HM","year":"2021","unstructured":"Yassine HM, Al-Jighefee H, Al-Sadeq DW, et al.. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2021, 102:181-7. 10.1016\/j.ijid.2020.10.042","journal-title":"Int J Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6685619","article-title":"Point-of-care diagnoses and assays based on lateral flow test","volume":"2021","author":"Pohanka M","year":"2021","unstructured":"Pohanka M. Point-of-care diagnoses and assays based on lateral flow test. Int J Anal Chem. 2021, 2021:1-9. 10.1155\/2021\/6685619","journal-title":"Int J Anal Chem"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000512535","article-title":"Clinical features of asymptomatic SARS-CoV-2 infection in hemodialysis patients","volume":"46","author":"Pizarro-S\u00e1nchez MS","year":"2021","unstructured":"Pizarro-S\u00e1nchez MS, Avello A, Mas-Fontao S, et al.. Clinical features of asymptomatic SARS-CoV-2 infection in hemodialysis patients. Kidney Blood Press Res. 2021, 46:126-34. 10.1159\/000512535","journal-title":"Kidney Blood Press Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2023.114825","article-title":"Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021","volume":"322","author":"M\u00f6gling R","year":"2023","unstructured":"M\u00f6gling R, Reimerink J, Stanoeva KR, et al.. Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021. J Virol Methods. 2023, 322:114825. 10.1016\/j.jviromet.2023.114825","journal-title":"J Virol Methods"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2022.113365","article-title":"Novel bridge multi-species ELISA for detection of SARS-CoV-2 antibodies","volume":"511","author":"Trabucchi A","year":"2022","unstructured":"Trabucchi A, Bombicino SS, Marf\u00eda JI, et al.. Novel bridge multi-species ELISA for detection of SARS-CoV-2 antibodies. J Immunol Methods. 2022, 511:113365. 10.1016\/j.jim.2022.113365","journal-title":"J Immunol Methods"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn8057","article-title":"Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection","volume":"14","author":"Evans JP","year":"2022","unstructured":"Evans JP, Zeng C, Carlin C, et al.. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci Transl Med. 2022, 14:8057. 10.1126\/scitranslmed.abn8057","journal-title":"Sci Transl Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.09.21252401","article-title":"Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays","volume":"11","author":"Santano R","year":"2021","unstructured":"Santano R, Barrios D, Crispi F, et al.. Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays. Sci Rep. 2021, 11:18984. 10.1101\/2021.03.09.21252401","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77555-4","article-title":"ELISA detection of SARS-CoV-2 antibodies in saliva","volume":"10","author":"MacMullan MA","year":"2020","unstructured":"MacMullan MA, Ibrayeva A, Trettner K, et al.. ELISA detection of SARS-CoV-2 antibodies in saliva. Sci Rep. 2020, 10:20818. 10.1038\/s41598-020-77555-4","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10943-020-01056-x","article-title":"The image of disease in religious, medical-astrological and social discourses: old Polish literature as an example of early modern European mentality","volume":"61","author":"Krzysztofik M","year":"2022","unstructured":"Krzysztofik M. The image of disease in religious, medical-astrological and social discourses: old Polish literature as an example of early modern European mentality. J Relig Health. 2022, 61:3340-9. 10.1007\/s10943-020-01056-x","journal-title":"J Relig Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2023.101473","article-title":"The effect of universal testing and treatment for HIV on health-related quality of life - an analysis of data from the HPTN 071 (PopART) cluster randomised trial","volume":"23","author":"Davis K","year":"2023","unstructured":"Davis K, Pickles M, Gregson S, et al.. The effect of universal testing and treatment for HIV on health-related quality of life - an analysis of data from the HPTN 071 (PopART) cluster randomised trial. SSM Popul Health. 2023, 23:101473. 10.1016\/j.ssmph.2023.101473","journal-title":"SSM Popul Health"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-05926-6","article-title":"Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID","volume":"23","author":"Vigil-V\u00e1zquez S","year":"2023","unstructured":"Vigil-V\u00e1zquez S, Manzanares \u00c1, Hernanz-Lobo A, et al.. Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID. BMC Pregnancy Childbirth. 2023, 23:623. 10.1186\/s12884-023-05926-6","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04338-22","article-title":"Development of a novel enzyme-linked immunosorbent assay and lateral flow test system for improved serodiagnosis of visceral leishmaniasis in different areas of endemicity","volume":"11","author":"Mahdavi R","year":"2023","unstructured":"Mahdavi R, Shams-Eldin H, Witt S, et al.. Development of a novel enzyme-linked immunosorbent assay and lateral flow test system for improved serodiagnosis of visceral leishmaniasis in different areas of endemicity. Microbiol Spectr. 2023, 11:e0433822. 10.1128\/spectrum.04338-22","journal-title":"Microbiol Spectr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40195-z","article-title":"Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology","volume":"14","author":"de Gier B","year":"2023","unstructured":"de Gier B, Huiberts AJ, Hoeve CE, et al.. Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology. Nat Commun. 2023, 14:4793. 10.1038\/s41467-023-40195-z","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266000-unveiling-the-quest-crafting-an-enzyme-linked-immunosorbent-assay-elisa-technique-to-uncover-covid-19-antibodies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:53:33Z","timestamp":1723442013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266000-unveiling-the-quest-crafting-an-enzyme-linked-immunosorbent-assay-elisa-technique-to-uncover-covid-19-antibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.66659","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,11]]}}}